Company / Cash per Share
Amphstar Pharmaceuticals, Inc. Cash per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$3.57
FY2025
5-year range
$2.66 / $3.57
FY2021-FY2025
Trend
+13.3%
vs FY2024
Sector context
#57 of 205
Health Care
What the data says
At $3.57, Amphstar Pharmaceuticals, Inc.'s cash per share ranks #57 of 205 in the Health Care sector. Cash per Share has fluctuated over the past 10 years, ranging from $1.42 in FY2017 to $3.57 in FY2025.
Based on SEC 10-K filings.
3.57 in FY2025 with a 5-year CAGR of +12.4%.
Improved from $3.00 to $3.57 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- +3.0%
- 5-Year CAGR
- +12.4%
- 10-Year CAGR
- -
Sector benchmark
#57 of 205 in Health CareTop 28% of 205This company $3.57 Sector average $72.93
▼
-95.1% below sector average
Key checks
Key Insights
- In FY2025, cash per share increased 13.3% year-over-year.
- Ranks #57 out of 205 companies in the Health Care sector.
- Lowest cash per share in the period was in FY2017.
Company context
Key Data Points
- Strong profit margin: 21.8%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.57 | +13.3% |
| FY2024 | $3.15 | +5.2% |
| FY2023 | $3.00 | -8.3% |
| FY2022 | $3.27 | +23.0% |
| FY2021 | $2.66 | +33.8% |
| FY2020 | $1.99 | +25.9% |
| FY2019 | $1.58 | -14.7% |
| FY2018 | $1.85 | +30.6% |
| FY2017 | $1.42 | -11.4% |
| FY2016 | $1.60 | +8.2% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026